Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Melo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 6, 2025
1β-Hydroxydeoxycholic acid as an endogenous biomarker in human plasma for assessment of drug-drug interaction with moderate CYP3A inhibitorYizhe Chen, Runlan Huo, Brian Melo, et al.
Journal of Chromatography. A|January 31, 2025
Emerging applications of quantitative supercritical fluid chromatography-tandem mass spectrometry for chiral bioanalysisInes C Santos, Zhihui Zhang, Lina Luo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2024
1β-Hydroxydeoxycholic Acid as an Endogenous Biomarker in Human Plasma for Assessment of CYP3A Clinical Drug-Drug Interaction PotentialYongjun Xue, Linna Wang, Runlan Huo, et al.
Biomedical Chromatography : BMC|January 4, 2012
An integrated bioanalytical method development and validation approach: case studiesY-J Xue, Brian Melo, Martha Vallejo, et al.
Bioanalysis|January 26, 2016
Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A inductionY-J Xue, Matthew Hoffmann, Zeen Tong, et al.
Leukemia & Lymphoma|August 26, 2016
Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvementKah-Lok Chan, Carrie van der Weyden, Christine Khoo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 6, 2025
1β-Hydroxydeoxycholic acid as an endogenous biomarker in human plasma for assessment of drug-drug interaction with moderate CYP3A inhibitorYizhe Chen, Runlan Huo, Brian Melo, et al.
Journal of Chromatography. A|January 31, 2025
Emerging applications of quantitative supercritical fluid chromatography-tandem mass spectrometry for chiral bioanalysisInes C Santos, Zhihui Zhang, Lina Luo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2024
1β-Hydroxydeoxycholic Acid as an Endogenous Biomarker in Human Plasma for Assessment of CYP3A Clinical Drug-Drug Interaction PotentialYongjun Xue, Linna Wang, Runlan Huo, et al.
Biomedical Chromatography : BMC|January 4, 2012
An integrated bioanalytical method development and validation approach: case studiesY-J Xue, Brian Melo, Martha Vallejo, et al.
Bioanalysis|January 26, 2016
Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A inductionY-J Xue, Matthew Hoffmann, Zeen Tong, et al.
Leukemia & Lymphoma|August 26, 2016
Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvementKah-Lok Chan, Carrie van der Weyden, Christine Khoo, et al.
Pageof 1